Close Menu

NEW YORK (360Dx) – Recently released changes to how market-based lab pricing data will be collected as part of the Protecting Access to Medicare Act do not go far enough to address concerns of the lab industry, lab groups said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.